Proliferation Assay:
CCK-8 Assay:
Drug discovery:Article Title: AR/ERK co-targeting triggers ferroptosis via FOXC2 in triple-negative breast cancer.
Article Snippet: 1Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China 2Department of Breast Surgery, Peking Union Medical College Hospital, Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China 3Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215000, China 4The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China 5Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming 650223, China 6Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
Western Blot:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
Transduction:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
Control:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
Concentration Assay:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
Phospho-proteomics:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
Expressing:Article Title: Neuropilin-1 acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.
Article Snippet: .. The KEGG pathway was analyzed using the KEGG Mapper. (I) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with 4-Hydroxylonchocarpin (15 μM in DMSO, MCE, HY-N2208) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (J) Western blot analyses of total and phosphorylated proteins of MAPK signaling pathway levels in M2 THP-1s transduced with lenti-NRP-1 or lenti-control and treated with Tyk2 phosphorylation inhibitor Deucravacitinib (1 μM in DMSO, TargetMol, T14687) or the vehicle control (DMSO, final concentration 0.1 %) for 48 h. (K) Immunoblotting analyses of CD206 expression in THP-1 cells transduced with lenti-NRP-1 or lenti-control and treated with siRNA targeting IL13Rα1. ..
other:Article Title: MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.
Article Snippet: A range of reagents was procured from various suppliers, including KRAS G12C inhibitors such as fulzerasib (#T73190, TargetMol, Boston, Massachusetts, USA), garsorasib (#E1578, Selleck, Shanghai, China), sotorasib (#T8684, TargetMol), and adagrasib (#T8369, TargetMol); Mitogen-activated protein kinase (MAPK) pathway inhibitors including trametinib (#T2125, TargetMol) and SCH772984 (#T6066, AR TIC LE IN PR ES S TargetMol); the pan-RAS inhibitor RMC-7977 (#T81263, TargetMol); ferroptosis inducers, including RSL3 (#R302648, Aladdin, Shanghai, China) and Imidazole ketone erastin (IKE) (#T5523, TargetMol); as well as other inhibitors of cell death such as ferrostatin-1 (fer-1) (#T6500, TargetMol), deferoxamine (DFO) (#T1637, TargetMol), Z-VAD-FMK (Z-VAD) (#T7020, TargetMol), and necrosulfonamide (necro) (#T6904, TargetMol).
|